Cite
MLA Citation
Joaquin Mateo et al.. “Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.” Lancet oncology, vol. 21, no. 1, 2020, pp. 162–174. http://access.bl.uk/ark:/81055/vdc_100098645680.0x000014